103 phenotypes from 6 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Wwoxem1Mald/Wwoxem1Mald FVB/N-Wwoxem1Mald	abnormal cerebellum vermis lobule morphology	J:339564
	abnormal fear/anxiety-related behavior	J:339564
	abnormal motor capabilities/coordination/movement	J:339564
	abnormal response to social novelty	J:339564
	absent cerebellum fissure	J:339564
	astrocytosis	J:339564
	cerebellum atrophy	J:339564
	cerebellum hypoplasia	J:339564
	cholestasis	J:339564
	convulsive seizures	J:339564
	decreased body weight	J:339564
	decreased locomotor activity	J:339564
	decreased oligodendrocyte number	J:339564
	decreased social investigation	J:339564
	enlarged gallbladder	J:339564
	normal growth/size/body region phenotype	J:339564
	normal homeostasis/metabolism phenotype	J:339564
	impaired coordination	J:339564
	increased thigmotaxis	J:339564
	limb grasping	J:339564
	liver degeneration	J:339564
	microgliosis	J:339564
	premature death	J:339564
	Purkinje cell degeneration	J:339564
	thin cerebellar granule layer	J:339564
	thin cerebellar molecular layer	J:339564
	tonic-clonic seizures	J:339564
WwoxGt(XG218)Byg/WwoxGt(XG218)Byg involves: 129P2/OlaHsd	decreased survivor rate	J:132078
	increased B cell derived lymphoma incidence	J:132078
	increased Leydig cell number	J:132078
	increased malignant tumor incidence	J:132078
	premature death	J:132078
	reduced male fertility	J:132078
	seminiferous tubule degeneration	J:132078
	testicular atrophy	J:132078
Wwoxtm1.1Mald/Wwoxtm1.1Mald involves: C57BL/6 * FVB/N	abnormal thymus cortex morphology	J:155406
	anemia	J:155406
	cachexia	J:155406
	decreased body weight	J:155406
	decreased bone mineral density	J:155406
	decreased bone trabecula number	J:155406
	decreased circulating bicarbonate level	J:155406
	decreased circulating calcium level	J:155406
	decreased circulating glucose level	J:155406
	decreased leukocyte cell number	J:155406
	decreased liver weight	J:155406
	decreased osteoblast cell number	J:155406
	decreased spleen weight	J:155406
	decreased thymus weight	J:155406
	decreased trabecular bone thickness	J:155406
	decreased trabecular bone volume	J:155406
	increased blood urea nitrogen level	J:155406
	increased brain weight	J:155406
	increased circulating chloride level	J:155406
	normal neoplasm	J:155406
	postnatal growth retardation	J:155406
	postnatal lethality, complete penetrance	J:155406
	small spleen	J:155406
	spleen atrophy	J:155406
Wwoxtm1Mald/Wwoxtm1Mald involves: 129S6/SvEvTac * C57BL/6	normal growth/size/body region phenotype	J:155406
	normal mortality/aging	J:155406
	normal reproductive system phenotype	J:155406
Wwoxtm1Ria/Wwox+ involves: 129X1/SvJ * C57BL/6	enlarged spleen	J:120064
	increased incidence of tumors by chemical induction	J:120064
	increased lung tumor incidence	J:120064
	increased tumor incidence	J:120064
Wwoxtm1Ria/Wwoxtm1Ria involves: 129X1/SvJ * C57BL/6	increased osteosarcoma incidence	J:120064
	premature death	J:120064
Wwoxtm1Ria/Wwoxtm1Ria involves: 129X1/SvJ * C57BL/6J	abnormal circulating enzyme level	J:138140
	abnormal homeostasis	J:146986
	abnormal osteoblast differentiation	J:138140
	abnormal osteoclast physiology	J:138140
	abnormal pituitary gland physiology	J:146986
	abnormal primary ovarian follicle morphology	J:146986
	abnormal skeleton development	J:138140
	abnormal skeleton morphology	J:138140
	abnormal trabecular bone morphology	J:138140
	cachexia	J:138140
	decreased body size	J:138140
	decreased bone mineral density	J:138140
	decreased circulating alkaline phosphatase level	J:138140
	decreased circulating aspartate transaminase level	J:138140
	decreased circulating calcium level	J:138140
	decreased circulating chloride level	J:138140
	decreased circulating cholesterol level	J:138140
	decreased circulating serum albumin level	J:138140
	decreased circulating sodium level	J:138140
	decreased circulating testosterone level	J:146986
	decreased circulating total protein level	J:138140
	decreased circulating triglyceride level	J:138140
	decreased compact bone thickness	J:138140
	decreased Leydig cell number	J:146986
	decreased theca cell number	J:146986
	hypoglycemia	J:138140
	increased adrenal gland weight	J:138140
	increased blood uric acid level	J:138140
	increased bone resorption	J:138140
	increased brain weight	J:138140
	increased circulating bilirubin level	J:138140
	increased circulating phosphate level	J:138140
	increased circulating potassium level	J:138140
	increased pituitary gland weight	J:138140
	postnatal growth retardation	J:138140
	postnatal lethality, complete penetrance	J:138140
	small ovary	J:146986
	small seminiferous tubules	J:146986
	small testis	J:146986
	testis hypoplasia	J:146986
	thin uterine horn	J:146986
Wwoxtm2.1Ria/Wwoxtm2.1Ria involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N	abnormal compact bone morphology	J:198845
	abnormal trabecular bone morphology	J:198845
	decreased body weight	J:198845
	decreased bone mineral density	J:198845
	decreased bone trabecula number	J:198845
	decreased compact bone area	J:198845
	decreased compact bone thickness	J:198845
	decreased trabecular bone connectivity density	J:198845
	decreased trabecular bone volume	J:198845
	hypoglycemia	J:198845
	increased skeletal tumor incidence	J:198845
	postnatal growth retardation	J:198845
	postnatal lethality, complete penetrance	J:198845